Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases.
Base editing is an emerging class of investigational precision genetic medicines designed to overcome the limitations of existing approaches and expand the potential of genetic medicine.
Our delivery strategy is to establish a suite of clinically validated technologies, including electroporation, nonviral and viral delivery modalities.